These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2147898)

  • 41. Changes in melatonin levels but not cortisol levels are associated with depression in patients with eating disorders.
    Kennedy SH; Garfinkel PE; Parienti V; Costa D; Brown GM
    Arch Gen Psychiatry; 1989 Jan; 46(1):73-8. PubMed ID: 2910222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dexamethasone suppression test in schizophrenia.
    Sawyer J; Jeffries JJ
    J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders.
    Sora I; Nishimon K; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):621-31. PubMed ID: 3708036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroendocrine responses in psychiatric and pain patients with major depression.
    Atkinson JH; Kremer EF; Risch SC; Dana R; Janowsky DS
    Biol Psychiatry; 1986 Jun; 21(7):612-20. PubMed ID: 3708035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of stress on the dexamethasone suppression test.
    Ceulemans DL; Westenberg HG; van Praag HM
    Psychiatry Res; 1985 Mar; 14(3):189-95. PubMed ID: 3858891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baseline plasma cortisol and dexamethasone test in unselected psychiatric inpatients.
    Volsan O; Berzewski H
    Psychopathology; 1985; 18(4):186-97. PubMed ID: 4089117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroendocrine differences among subtypes of schizophrenic disorder? An investigation with the dexamethasone suppression test.
    Banki CM; Arató M; Rihmer Z
    Neuropsychobiology; 1984; 11(3):174-7. PubMed ID: 6472604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response to dexamethasone in psychotic depression.
    Caroff S; Winokur A; Rieger W; Schweizer E; Amsterdam J
    Psychiatry Res; 1983 Jan; 8(1):59-64. PubMed ID: 6572988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ
    Am J Psychiatry; 1985 May; 142(5):659-60. PubMed ID: 3985211
    [No Abstract]   [Full Text] [Related]  

  • 55. Dexamethasone suppression test in schizophrenia. A study and review.
    Asnis GM; Eisenberg J; Lemus CZ; Halbreich U
    Neuropsychobiology; 1986; 15(3-4):109-13. PubMed ID: 3785640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma 11-deoxycortisol and cortisol following dexamethasone in psychiatric patients.
    Joyce PR; Elder PA; Clifford JC; Brinded PJ; Donald RA
    J Psychiatr Res; 1988; 22(1):29-33. PubMed ID: 3397907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cortisol secretion in prepubertal children with major depressive disorder. Episode and recovery.
    Puig-Antich J; Dahl R; Ryan N; Novacenko H; Goetz D; Goetz R; Twomey J; Klepper T
    Arch Gen Psychiatry; 1989 Sep; 46(9):801-9. PubMed ID: 2673131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.
    Akil H; Haskett RF; Young EA; Grunhaus L; Kotun J; Weinberg V; Greden J; Watson SJ
    Biol Psychiatry; 1993 Jan; 33(2):73-85. PubMed ID: 8382535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.